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MAPKKK dual leucine zipper-bearing kinases (DLKs)
are regulators of synaptic development and axon
regeneration. The mechanisms underlying their acti-
vation are not fully understood. Here, we show that
C. elegans DLK-1 is activated by a Ca2+-dependent
switch from inactive heteromeric to active homo-
meric protein complexes. We identify a DLK-1 iso-
form, DLK-1S, that shares identical kinase and
leucine zipper domainswith the previously described
long isoform DLK-1L but acts to inhibit DLK-1 func-
tion by binding to DLK-1L. The switch between
homo- or heteromeric DLK-1 complexes is influ-
enced by Ca2+ concentration. A conserved hexapep-
tide in the DLK-1L C terminus is essential for DLK-1
activity and is required for Ca2+ regulation. The
mammalian DLK-1 homolog MAP3K13 contains an
identical C-terminal hexapeptide and can function-
ally complement dlk-1 mutants, suggesting that the
DLK activation mechanism is conserved. The DLK
activation mechanism is ideally suited for rapid and
spatially controlled signal transduction in response
to axonal injury and synaptic activity.
INTRODUCTION
MAP kinase-mediated signal transduction pathways have been
implicated in many aspects of neuronal development and func-
tion (Huang and Reichardt, 2001; Ji et al., 2009; Mielke and Her-
degen, 2000; Samuels et al., 2009; Subramaniam and Unsicker,
2010; Thomas and Huganir, 2004). As neurons are highly polar-
ized cells receiving spatially segregated information, a critical
aspect of MAP kinases is their ability to be locally regulated
within cells and with tight temporal control. For example, in
developing axons, local activation of p38 and Erk MAP kinases
by the MAPKK MEK1/MEK2 is differentially required for BDNF
and netrin-1-induced growth cone turning (Ming et al., 2002)
and slit-2-induced growth cone collapse (Piper et al., 2006).534 Neuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc.Local activation of MAP kinases by neuronal excitation plays
important roles in dendritic spine dynamics (Wu et al., 2001).
Axonal injury can trigger activation of Erk at the injury site to
regulate signal transduction via retrograde transport (Perlson
et al., 2005). In a typical MAP kinase cascade, activation of the
upstreamMAPKKK is a critical control point for signal specificity
and amplification (Chang and Karin, 2001). However, our knowl-
edge of how MAPKKKs are activated in vivo by local neuronal
signals remains limited.
The dual leucine zipper-bearing kinases (DLKs) are key regula-
tors of synapse formation, axon regeneration, and axondegener-
ation from C. elegans to mammals (Collins et al., 2006; Hammar-
lund et al., 2009; Itoh et al., 2009; Miller et al., 2009; Nakata et al.,
2005; Xiong andCollins, 2012; Xiong et al., 2010; Yan et al., 2009;
Shin et al., 2012). The DLK kinases belong to the mixed-lineage
family of MAPKKKs (Holzman et al., 1994). The hallmark of these
kinases is a leucine zipper domain, which can mediate protein
dimerization or oligomerization and has been implicated in
kinase activation (Nihalani et al., 2000). Although C. elegans
and Drosophila each has only one gene encoding DLK kinase
(Nakata et al., 2005; Collins et al., 2006), mammalian genomes
encode two closely related DLK family kinases known as
MAP3K12/DLK/MUK/ZPK (Blouin et al., 1996; Hirai et al., 1996;
Holzman et al., 1994) and MAP3K13/LZK (Sakuma et al., 1997).
Both kinases are widely expressed in the nervous system,
and DLK/MAP3K12 was identified as a synapse-associated
MAPKKK (Mata et al., 1996). The in vivo functions of these
kinases were discovered through genetic studies of the synaptic
E3 ubiquitin ligases known as PHR proteins, includingC. elegans
RPM-1, Drosophila Highwire, mouse Phr1, and human Pam
(Collins et al., 2006; Lewcock et al., 2007; Nakata et al., 2005).
Activated DLK kinases are targeted for degradation by these
E3 ligases, resulting in a tight control of duration of signal trans-
duction. In C. elegans, loss-of-function mutations in dlk-1 genet-
ically suppress the neuronal defects of rpm-1mutants, but dlk-1
mutants themselves are viable and grossly normal (Nakata et al.,
2005). Constitutive activation of the DLK-1 pathway induces
developmental defects mimicking rpm-1(lf) (Nakata et al.,
2005). Moreover, expression of a constitutively active MAK-2,
a downstream kinase of DLK-1, at synapses can disrupt synapse
morphology and decrease synapse number (Yan et al., 2009),
suggesting that local activation of the DLK-1 pathway plays
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Figure 1. DLK-1 Encodes Two Isoforms
with Different Functions
(A) Structure of the dlk-1 locus. Black boxes are
exons; red star marks the alternative intron 7. The
deletion allele tm4024 truncates kinase domain in
both DLK-1L and DLK-1S followed by a premature
stop codon. ju476 contains a 5 bp insertion,
inducing a premature stop codon only in DLK-1L.
(B) Schematic comparison of DLK-1 isoforms and
their human homologs. Distribution of selected
genetic loss-of-function mutations in DLK-1 is
shown as an amino acid change. The full list of
dlk-1 mutations is in Table S1. The accession
numbers for human MAP3K13, MAP3K12L, and
MAP3K12S are EAW78225.1, NM_006301.3, and
BC050050.1, respectively.
(C and D) The DLK-1S isoform does not pro-
vide normal function of DLK-1 and antagonizes
DLK-1L.
(C) Images of SNB-1-GFP puncta expressed in the
GABAergic motor neurons (juIs1 [Punc-25-SNB-1-
GFP]) in young adults of genotypes indicated. The
graph shows quantification of SNB-1-GFP puncta
number of corresponding genotypes. n = number
of animals; scale bar represents 10 mm. Similar
changes are observed for the presynaptic active
zone protein UNC-10/RIM (see Figure S2A).
(D) Images show touch neuron axons labeled by
muIs32 [Pmec-7-GFP] in young adults in regions
illustrated above. In wild-type ALM, axons end
before the tip of the nose and PLM axons end
before ALM cell bodies. In rpm-1, both ALM and
PLM axons overextend, marked with red and
yellow stars, respectively. The PLM neuron also
has one synaptic branch near the vulva (purple
stars), which is absent in half of rpm-1 animals.
Quantification of axon termination defects of PLM
and ALM is shown as a percentage of the total
number of animals. Quantification of PLM synaptic
branch shows a similar pattern (data not shown).
Data are shown as mean ± SEM in (C) and mean ±
SEP in (D). Student’s t test for synaptic puncta in
(C) and Fisher’s exact test for axonal morphology
in (D). *p < 0.05; **p < 0.01; ns, not significant.
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DLK-1 Activation by Isoform-Specific Interactionsimportant roles in synapse formation. In adult neurons, DLK-1 is
essential for injured axons to regenerate, and its activity is
required within a limited time window after injury (Hammarlund
et al., 2009; Yan et al., 2009). These results indicate that the acti-
vation of DLK-1 must be precisely controlled in time and space
by neuronal activity or injury.
Despite extensive studies of DLK kinase function and their
negative regulation by PHR proteins, the mechanisms by which
DLK kinases are activated have remained elusive. Here we
identify a short isoform, DLK-1S, that shares identical kinase
and leucine zipper domains with the previously reported long
isoform DLK-1L but binds to and inhibits the activity of the active
DLK-1L. We identify a unique hexapeptide at the DLK-1L C
terminus that plays critical roles in DLK-1 isoform-specific inter-
actions. We further show that mammalian MAP3K13 contains
identical hexapeptide and can complement DLK-1 function.Our results reveal a mechanism for tight spatial and temporal
control of MAPKKK activity in neurons.
RESULTS
The dlk-1 Locus Encodes Two Isoforms with
Antagonistic Functions
The previously reported C. elegans DLK-1 protein contains 928
amino acid (aa) residues, including a kinase domain (aa 133–
382) and a leucine zipper (LZ, aa 459–480) (Figures 1A and
1B). By our analysis of new dlk-1 cDNA clones, and subsequently
by RT-PCR and northern blotting, we found that the dlk-1 locus
generates a second shorter transcript by use of an alternative
polyadenylation site in intron 7 (Figure 1A, Experimental Proce-
dures, and see Figure S1A available online). This transcript
encodes a DLK-1 isoform of 577 residues. We here name theNeuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc. 535
Neuron
DLK-1 Activation by Isoform-Specific Interactionstwo isoforms DLK-1L (long) and DLK-1S (short). Both isoforms
contain identical N-terminal kinase and LZ domains. The C
terminus of DLK-1S consists of 11 isoform-specific residues,
whereas the DLK-1L-specific C terminus contains 361 residues.
Neither C-terminal domain contains known protein motifs. Anal-
ysis of expressed sequence tags (ESTs) for human and rat DLK
family members indicates that these genes can also encode long
and short isoforms (Figure 1B).
To gain clues about the functions of the two isoforms of DLK-1,
we took advantage of our collection of genetic loss-of-function
mutations in dlk-1, all of which were isolated as suppressors of
rpm-1(lf) (Nakata et al., 2005). A large number of missense
mutations affect conserved residues in the kinase domain
(Figures 1B, S1B, and S1C and Table S1); one mutation (ju591)
changes the conserved Leu at residue 459 in the LZ domain (Fig-
ure 1B). The strong loss-of-function phenotypes induced by
these mutations are consistent with the essential roles of the
kinase and LZ domains (Figure S1C). Unexpectedly, another
set of strong loss-of-function mutations affect the C terminus
specific to DLK-1L and are not predicted to affect DLK-1S
(Figures 1B and S1C and Table S1). RT-PCR analysis showed
that DLK-1S transcripts were produced at normal levels in the
C-terminal mutants (Figure S1D). These observations raised
the possibility that DLK-1S does not have the same activity as
DLK-1L.
To more directly address the role of DLK-1S, we assayed its
function in synaptogenesis and developmental axon outgrowth,
using transgenic rescue of the phenotypes of dlk-1(lf); rpm-1(lf)
double mutants. rpm-1 mutants exhibit defects in motor neuron
synapse development and in touch neuron axon growth (Schae-
fer et al., 2000; Zhen et al., 2000). Both synaptic and axonal
rpm-1 defects are strongly suppressed by dlk-1(lf) (Nakata
et al., 2005) (Figures 1C, 1D, and S2A). Neuronal expression of
a DLK-1L cDNA at low concentrations fully rescued the dlk-1(lf)
suppression phenotype (Figures 1C, 1D, and S2A, juEx2789,
juEx2519). Expression of a DLK-1 minigene that produces both
DLK-1L and DLK-1S proteins at comparable levels (Figure S2B)
also fully rescued dlk-1 suppression phenotype (Figure 1D,
juEx3452). In contrast, expression of DLK-1S alone showed no
rescuing activity (Figures 1C and 1D, juEx2791, juEx2523),
consistent with the interpretation that DLK-1S cannot substitute
for DLK-1L. Furthermore, the rescuing activity of DLK-1L was
strongly attenuated by co-overexpression with DLK-1S (Figures
1C and 1D, juEx2802, juEx2813). This inhibitory effect of DLK-1S
was eliminated when the LZ domain was deleted from DLK-1S
(Figure S2C). However, expression of a kinase-dead mutant
DLK-1S(K162A), in which the Lys162 at the ATP binding site of
the kinase domain was mutated to Ala (Nakata et al., 2005), in-
hibited DLK-1L to a similar degree as did wild-type DLK-1S (Fig-
ure S2C). These data suggest that the ability of DLK-1S to inhibit
DLK-1L requires its LZ domain but not its kinase activity. As
a further test for the role of DLK-1S, we expressed various
DLK-1 constructs in the wild-type background (Figure S2D).
Overexpression of DLK-1L alone caused abnormal neuronal
development, whereas overexpression of DLK-1(mini) gene
had a much weaker effect. Removing intron 7 from DLK-
1(mini), which would prevent production of DLK-1S, resulted in
gain-of-function effects similar to DLK-1(L). Finally, to address536 Neuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc.whether transgenically expressed DLK-1S could interfere with
endogenous DLK-1L, we overexpressed DLK-1S in rpm-1(lf)
single mutants and observed significant suppression of rpm-
1(lf) phenotypes (Figure S3A). Together, these analyses demon-
strate that despite sharing identical kinase and LZ domains,
DLK-1S is a potent inhibitor of DLK-1L function.
DLK-1L Activity Requires a Conserved Motif in Its
Extreme C Terminus
If DLK-1S acts as an endogenous inhibitory isoform, how does
DLK-1L become activated at all? Since DLK-1L and DLK-1S
differ only in their C termini, we hypothesized that the C terminus
of DLK-1L may contain elements important for its kinase activa-
tion and that DLK-1S may act by preventing the interactions
between such elements and the kinase domain. To test this
idea, we generated a series of DLK-1L variants in which the
C terminus was either truncated or contained internal deletions
(Supplemental Experimental Procedures) and assayed rescuing
activity of these constructs in the dlk-1(lf); rpm-1(lf) double
mutant strain (Figure 2, Table S2). We found that a region of 25
amino acids from residues 856 to 881 in the DLK-1L C terminus
was necessary for DLK-1L activity (Figure 2, juEx3586). Remark-
ably, a construct lacking all of the DLK-1L C terminus except
for aa 856–881 recapitulated the activity of the full-length
DLK-1L (Figure 2, juEx3657), suggesting that this region is
sufficient for DLK-1L regulation. Upon closer inspection of the
amino acid sequences, we found a six residue motif SDGLSD
(aa 874–879, hereafter referred to as the hexapeptide) that is
completely conserved betweenC. elegansDLK-1 and vertebrate
MAP3K13/LZK (Figure 3A); the remainder of the C termini of
these kinases show little sequence conservation. Moreover,
dlk-1(ju620), a strong loss-of-function mutation, results in a mis-
sense alteration (G870E) adjacent to this hexapeptide. We ex-
pressed a DLK-1L(G870E) mutant cDNA and observed little
rescuing activity (Figure 2, juEx3659). Deleting the conserved
hexapeptide in DLK-1L also completely abolished rescuing
activity (Figure 2, juEx4098). Together, these results identify
the conserved C-terminal hexapeptide as critical for DLK-1L
function.
The Regulatory Roles of the C-Terminal Hexapeptide in
DLK-1 Isoform-Specific Interactions
To determine how DLK-1S interacts with DLK-1L and how
the C-terminal hexapeptide regulates their interaction, we next
performed protein interaction studies using yeast two-hybrid
assays. We found that full-length DLK-1L interacted with itself
and also with DLK-1S (Figure 3B). Removal of the LZ domain
in DLK-1L or DLK-1S eliminated these interactions. Unexpect-
edly, despite containing the LZ domain, DLK-1S did not show
interaction with itself, suggesting that the LZ domain is not suffi-
cient for DLK-1 dimerization or oligomerization. To test the role of
the C-terminal hexapeptide SDGLSD in the interactions between
DLK-1 isoforms, we deleted it from DLK-1L. We found that
a DLK-1L construct lacking the hexapeptide failed to show any
homomeric interaction and, instead, displayed an enhanced het-
eromeric interaction with DLK-1S (Figure 3C). These results sug-
gest that the C-terminal hexapeptide plays a critical regulatory
role in DLK-1 isoform-specific interactions.
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Figure 2. A Small Domain of the DLK-1L
C Terminus Is Required for DLK-1 Activity
Transgenic expression of C-terminal truncated
DLK-1L variants in dlk-1(ju476);rpm-1(ju44) double
mutants identifies a small region (aa 856–881) and
a conserved hexapeptide (aa 874–879) as required
for DLK-1L activity. Data are shown as mean ±
SEP. Statistics, Fisher’s exact test: *p < 0.05; **p <
0.01; ns, not significant.
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DLK-1 Activation by Isoform-Specific InteractionsSince theC-terminal aa 856–881 region can endowa truncated
DLK-1(kinase+LZ) with complete function (Figure 2, juEx3588),
we tested whether this domain might interact with the kinase
domain. In yeast two-hybrid assays, we observed that the aa
850–881 region interacted with the kinase domain of DLK-1 (Fig-
ure 3E). The hexapeptide SDGLSD contains two potential phos-
phorylation sites (Ser 874 and Ser878, Figure 3A). We addressed
whether these serines were sites of regulation by generating
phosphomimetic and nonphosphorylatable forms of the hexa-
peptide. We found that full-length DLK-1L containing phospho-
mimetic (S874E, S878E) hexapeptide showed stronger binding
to itself (Figure 3C). Conversely, full-length DLK-1L containing
nonphosphorylatable (S874A, S878A) hexapeptide showed an
enhanced interaction with DLK-1S (Figure 3C). The phosphomi-
metic C-terminal aa 850–881 region also showed stronger bind-
ing to the kinase domain of DLK-1 (Figure 3E). The C-terminal
domain alone did not interact with itself in yeast two-hybrid
assays (data not shown), although a region of 209 amino acids
between LZ domain and the hexapeptide was necessary for
DLK-1L to interact with DLK-1S (Figure 3D). Taken together,
the results from yeast two-hybrid interaction assays suggest
that phosphorylation of the DLK-1L hexapeptide could regulate
the balance between active DLK-1L homomers and inactive
DLK-1L/S heteromers.
To address the in vivo importance of DLK-1 C-terminal
hexapeptide phosphorylation, we turned to transgenic expres-
sion. DLK-1L with a nonphosphorylatable hexapeptide (S874A,Neuron 76, 534–548,S878A) was expressed normally (Fig-
ure S4) but lacked rescuing activity
(Figure 4A, juEx4708). However, coex-
pression of the phosphomimetic DLK-
1L(S874E, S878E) overcame the inhibi-
tory effects of DLK-1S (Figure 4A,
juEx4694). Strikingly, coexpression of
DLK-1S with the DLK-1L C-terminal 328
aa or the aa 850–881 fragment in dlk-1;
rpm-1 mutants significantly rescued the
suppression effects of dlk-1(lf) (Figure 4A,
juEx3661, juEx3729). These results sug-
gest that the C terminus of DLK-1L can
activate DLK-1 in trans.
Vertebrate MAP3K13/LZK proteins
containC-terminal hexapeptides identical
to that ofDLK-1L (Figure 3A).We therefore
tested whether the function of DLK-1L
was conserved with human MAP3K13.
The kinase domain of MAP3K13 is 60%identical to that of DLK-1 (Figure S1B). We found that DLK-1L
(aa 850–881) could bind to the kinase domain of human
MAP3K13 in the yeast two-hybrid assay (Figure 3F). We then ex-
pressed the humanMAP3K13 cDNAunder a panneural promoter
in dlk-1(lf); rpm-1(lf) animals (Supplemental Experimental Proce-
dures) and observed a significant rescue of dlk-1(lf) phenotypes
(Figures4BandS3, juEx4748). In contrast, expressionof amutant
MAP3K13 containing Ala mutations in the hexapeptide (S903A,
S907A) did not rescue dlk-1(lf) (Figure 4B, juEx4995). The
MAP3K12/DLK shares an almost identical kinase domain with
MAP3K13/LZK but lacks the C-terminal hexapeptide. However,
expression of MAP3K12/DLK alone failed to rescue dlk-1 pheno-
types (Figure 4B, juEx4701). Interestingly, coexpression of
MAP3K12/DLK with a fragment containing the DLK-1 C-terminal
hexapeptide partially rescued dlk-1(lf) (Figure 4B, juEx5167).
These results show that human MAP3K13 complements dlk-1
function and suggest thatMAP3K13 can be activated by a similar
mechanism involving the conserved hexapeptide.
DLK-1L and DLK-1S Colocalize at Synapses and in
Axons
Previous studies have shown that DLK-1L is predominantly
localized at synapses and detectable along axons (Abrams
et al., 2008; Nakata et al., 2005). We next investigated where
the DLK-1 isoform interactions could occur in neurons. We ex-
pressed functional XFP-DLK-1 fusion proteins in motor neurons
and touch neurons (Table S2). Coexpressed YFP-DLK-1L andNovember 8, 2012 ª2012 Elsevier Inc. 537
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Figure 3. DLK-1L Can Bind to Itself or to DLK-1S, and the Interactions Are Regulated by a C-Terminal Conserved Hexapeptide
(A) Sequence conservation of the C-terminal peptide of DLK-1L (aa 868–881) with human MAP3K13/LZK (accession number EAW78225.1), mouse (accession
number NM_172821.3), Bos taurus (accession number NM_001101853.1), and Xenopus laevis (accession number NM_001172189.1). Asterisk marks dlk-1
(ju620) mutation. Sequence alignments used ClustW. Protein phosphorylation sites were predicted by the NetPhos program (http://www.cbs.dtu.dk/services/
NetPhos).
(B–F) Yeast cells were plated in a dilution series on Trp– Leu– media (left). Histidine (His) selection plates contained 10 mM 3-AT (right).
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AB
Figure 4. Effects of the C-Terminal Hexa-
peptide on DLK-1 Activation and Functional
Conservation of Human MAP3K13
(A) Coexpressing the DLK-1L C terminus (aa 566–
928) or the conserved domain (aa 850–881) with
DLK-1S shows significant rescuing activity. DLK-
1L containing nonphosphorylatable mutations of
the hexapeptide does not rescue the suppression
effects of dlk-1(ju476). DLK-1L containing the
phosphomimetic mutations of the hexapeptide
overcomes the inhibition of DLK-1S.
(B) Panneural expression of human MAP3K13, but
not MAP3K12, significantly rescues the sup-
pression effects of dlk-1(ju476). Coexpression of
MAP3K12 with the DLK-1 C-terminal hexapeptide
partially rescues the suppression effects of dlk-1
(ju476). Data are shown as mean ± SEP. Statistics,
Fisher’s exact test: *p < 0.05; **p < 0.01; ns, not
significant.
Neuron
DLK-1 Activation by Isoform-Specific InteractionsCFP-DLK-1S showed punctate colocalization patterns at motor
neuron synapses and in touch neuron axons (Figures 5A and 5B).
When expressed separately, GFP-DLK-1L showed punctate
patterns in both wild-type and dlk-1 mutants (Figure 5C). GFP-(B) DLK-1S binds to DLK-1L. BD, GAL4 binding domain; AD, GAL4 activation domain; V, empty vector; L
deletion.
(C) The C-terminal hexapeptide regulates DLK-1 interactions. L(D), DLK-1L(D874-879); L(EE), DLK-1L(S874E
(D) aa 605–814 of DLK-1L are also required for the interactions between DLK-1L and DLK-1S.
(E) aa 850–881 of DLK-1L bind to the kinase domain (KiD). The interaction is noticeably enhanced by phosp
nonphosphorylatable mutations (AA) of the hexapeptide.
(F) The DLK-1L C-terminal aa 850–881 interacts with the kinase domain of human MAP3K13 (KiD(H)).
Neuron 76, 534–548,DLK-1S showed a similar punctate
pattern in wild-type animals but became
diffuse in dlk-1(tm4024) mutants, which
lack both DLK-1L and DLK-1S, or in dlk-
1(ju591) mutants, in which the conserved
Leu in the LZ domain of both DLK-1L
and DLK-1S is mutated (Figures 1B
and 5C). Moreover, removal of the LZ
domain caused GFP-DLK-1S(DLZ) to be
diffuse. These results are consistent with
the DLK-1L and DLK-1S interaction
occurring in vivo and show that the
axonal localization of DLK-1S relies on
its binding to DLK-1L through the LZ
domain. Our previous studies showed
that inactive DLK-1L(K162A) protein is
more stable than wild-type DLK-1L
(Abrams et al., 2008). We found that over-
expression of DLK-1S resulted in signifi-
cant increase of GFP-DLK-1L expression
(Figure S3B). In rpm-1(lf) mutants, the
expression level of GFP-DLK-1S was
not altered (Figure S3C). These data are
consistent with the conclusion that
binding of DLK-1S to DLK-1L keeps
DLK-1L inactive. We further found thatgreen fluorescent protein (GFP)-tagged C terminus (aa 566–
928) of DLK-1L recapitulated full-length DLK-1L localization (Fig-
ure 5C). However, phosphomimetic or nonphosphorylatable
mutations of the hexapeptide did not change DLK-1L, DLK-1L; S, DLK-1S; DLZ, leucine zipper domain
, S878E); L(AA), DLK-1L(S874A, S878A).
homimetic mutations (EE) and slightly reduced by
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Figure 5. DLK-1S Colocalizes with DLK-1L
in Neurons, Dependent on the LZ Domain
(A) Confocal stack images of functional CFP-DLK-
1L and mCherry-DLK-1S (juEx3102) coexpressed
in GABAergic motor neurons show that DLK-1L
and DLK-1S are colocalized at synapses. Scale
bar represents 10 mm.
(B) Confocal stack images of functional CFP-DLK-
1L and YFP-DLK-1S (juEx3709) coexpressed in
touch neuron axons. Scale bar represents 10 mm.
(C) Axonal punctate localization of DLK-1S re-
quires its binding to DLK-1L through the LZ
domain. The DLK-1L-specific C terminus is suffi-
cient for its axonal localization. Shown are repre-
sentative confocal images of functional GFP-DLK-
1L and GFP-DLK-1S. DLK-1S without LZ domain
is diffuse in axons, and DLK-1S loses axonal
punctate localization in dlk-1(tm4024) or dlk-1
(ju591), a leucine zipper mutation. Cell bodies are
marked by asterisks. Enlarged axonal pictures are
shown on right. Scale bars represent 10 mm.
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DLK-1 Activation by Isoform-Specific Interactionslocalization (Figure S4). We conclude that the C terminus of DLK-
1L is not only required for DLK-1L activity but also necessary for
its subcellular localization in neurons.
Isoform-Dependent Regulation of DLK-1 Activity Is
Critical for Axon Regeneration
Howmight the isoform-dependent interaction of DLK-1 be regu-
lated in vivo? To address this question, we focused on the func-
tion of DLK-1 in adult neurons. In dlk-1(lf) adult animals, injured
axons fail to regrow (Hammarlund et al., 2009; Yan et al., 2009).
Overexpression of DLK-1(mini) completely rescued the regener-
ation failure of injured PLM axons in dlk-1(tm4024) mutants540 Neuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc.(Figures 6A and 6B, juEx3757). Overex-
pression of DLK-1L not only rescued the
regeneration failure, but also greatly
enhanced the overall extent of axon re-
growth (juEx2789) (Hammarlund et al.,
2009; Yan et al., 2009). Paralleling our
observations indeveloping neurons, over-
expression of DLK-1S did not rescue the
regeneration failure of dlk-1(lf) mutants
(juEx2791) and blocked the regrowth-
enhancing effects of DLK-1L (juEx2815).
The inhibitory activity of DLK-1S required
its LZ domain (juEx2881). However, DLK-
1L(EE) with C-terminal phosphomimetic
mutations showed regrowth-enhancing
effects when coexpressed with DLK-1S
(juEx4694), suggesting that DLK-1S is
less able to inhibit DLK-1L, whose hexa-
peptide is phosphorylated.
As axon regeneration is highly sensitive
to the dosage of DLK-1, we were con-
cerned that the observed effects could
be confounded by the variable levels of
overexpression associated with multi-
copy extrachromosomal transgenes. Wetherefore generated single-copy transgene expressing DLK-1S
or DLK-1L driven by the rgef-1 panneural promoter, using the
Mos-SCI technique (Frøkjaer-Jensen et al., 2008) (Experimental
Procedures). Single-copy expression of DLK-1S (juSi46) in wild-
type animals significantly impaired PLM neuron axon regenera-
tion, while single-copy expression of DLK-1L (juSi50) strongly
enhanced regeneration in wild-type and in dlk-1(tm4024) mu-
tants that lack both DLK-1L andDLK-1S (Figure 6C). Importantly,
expression of DLK-1L from juSi50 showed weak rescue of
the failure of axon regeneration in dlk-1(ju476) mutants, which
express intact DLK-1S (Figures S1D and 6C). These results not
only reaffirm that DLK-1S has potent and specific antagonistic
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Figure 6. DLK-1S Negatively Regulates DLK-1L Function in Adult PLM Axon Regeneration
(A) Images are confocal micrographs of PLM neurons expressing different DLK-1 isoforms at 24 hr after axotomy.
(B) Quantitation of PLM regrowth at 24 hr after axotomy. Expression of DLK-1L restores axon regeneration ability in dlk-1(tm4024). Coexpressing DLK-1S, but not
DLK-1S(DLZ), attenuates DLK-1L rescue ability. Expression of DLK-1L(EE) overcomes the inhibitory effects of DLK-1S.
(C) Effects of single-copy insertion transgenes of DLK-1 isoforms expressed under the panneural rgef-1 promoter. Single-copy insertion of DLK-1S (juSi46) is
sufficient to inhibit regeneration in wild-type. Single-copy expression of DLK-1L (juSi50) increases regeneration length in dlk-1(tm4024), but not in dlk-1(ju476) that
also expresses DLK-1S. zdIs5 (Pmec-4-GFP) was used to visualize axons for axotomy. n = number of animals. Data are shown as mean ± SEM; statistics,
ANOVA, *p < 0.05; **p < 0.01; ns, not significant. Scale bar represents 10 mm.
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DLK-1 Activation by Isoform-Specific Interactionseffects on DLK-1L in axon regeneration, but also suggest that
axonal injury can trigger DLK-1L activation by releasing the en-
dogenous inhibition imposed by DLK-1S. The similar enhanced
regeneration by expression of DLK-1L from single-copy trans-
gene in both wild-type and dlk-1(tm4024) implies that the forma-
tion of active DLK-1L/L homomeric protein complexes is under
the control of injury signals.Axotomy Promotes Accumulation of DLK-1L
at Injury Sites
We next investigated how axonal injury might modulate the
association of DLK-1L and DLK-1S. We performed live imaging
in PLM neurons expressing GFP-DLK-1L or GFP-DLK-1S, after
laser axotomy of PLM in L4 animals as described (Wu et al.,
2007). Within seconds after axotomy, GFP-DLK-1L visiblyNeuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc. 541
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Figure 7. Axotomy Triggers Local Accumu-
lation of DLK-1L but Not DLK-1S at the
Injury Site
(A) Local accumulation of GFP-DLK-1L at severed
ends of axons within minutes of damage. Time
0 refers to laser axotomy. Note accumulation both
in proximal (right) and distal (left) axon fragments.
Images were taken every 9 s for 5 min using
spinning-disc confocal microscopy. In order to
visualize dynamics of GFP-DLK-1 in axons, we
used higher imaging laser energy and longer
exposure time than those in Figure 5A.
(B) Normalized intensity of GFP fluorescence in
a 3 mm region of the proximal axon near cut sites
(region of interest [ROI], red rectangles) at different
time points after axotomy. DLK-1L, DLK-1S, and
DLK-1L(AA) fluorescent intensity change (F/F0)
differed (p < 0.05), observed from 36 s post-
axotomy to the end of the experiments. Cytosolic
GFP in muIs32 was used as a negative control.
Data are shown as mean ± SEM; statistics,
Student’s t test. n R 10 from two independent
recordings. Scale bars represent 10 mm.
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DLK-1 Activation by Isoform-Specific Interactionsaccumulated at cut sites and continued to increase over the
recording time (5–7min) (Figure 7 and Experimental Procedures).
In contrast, GFP-DLK-1S showed no obvious changes at cut
sites; cytosolic GFP decreased in intensity during the same
period of imaging (Figure 7). Since DLK-1L(S874A, S878A)
lacked activity and could bind to DLK-1S more strongly than to
wild-type DLK-1L (Figure 3C), we imaged its dynamics and
found that GFP-DLK-1L(S874A, S878A) did not show significant
changes immediately after axotomy (Figure 7B). The differential
localization of DLK-1L and DLK-1L(AA) upon axonal injury is
consistent with DLK-1 becoming dissociated from DLK-1S at
the cut site in response to injury.
High Concentration of Ca2+ Can Trigger the Dissociation
of DLK-1L/DLK-1S
We next addressed the mechanism by which axotomy might
regulate DLK-1 isoform-mediated activation. Axotomy causes
a wide range of changes in axons, including membrane break-
age, disruption of cytoskeleton and organelle trafficking, and
transient increases in Ca2+ (Barron, 2004; Stirling and Stys,
2010; Wang and Jin, 2011). Among these, Ca2+ increase is one
of the earliest events, and previous studies have shown that
increasing Ca2+ levels can promote axon regeneration in a
DLK-1-dependent manner (Ghosh-Roy et al., 2010). To test
whether Ca2+ can influence DLK-1 isoform interactions, we first
turned to heterologous expression in cultured cells, which al-
lowed us to detect DLK-1 protein interactions after acute manip-
ulation of Ca2+. We coexpressed FLAG-DLK-1L, HA-DLK-1L,
and HA-DLK-1S in HEK293 cells and stimulated the cells using
the Ca2+ ionophore ionomycin, with or without the Ca2+ chelator
BAPTA-AM (see Experimental Procedures). We then immu-
noprecipitated FLAG-DLK-1L and quantitated the amount of542 Neuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc.coimmunoprecipitated HA-DLK-1L and
HA-DLK-1S by western blotting. Without
ionomycin stimulation, DLK-1L waspredominantly bound to DLK-1S (Figure 8A). Ionomycin treat-
ment led to a 2-fold decrease in the amount of coimmunopreci-
pitated DLK-1S, accompanied with a 2-fold increase of coimmu-
noprecipitated DLK-1L (Figures 8A and 8B). These results
support our two-hybrid interaction studies. Ionomycin treatment
at different concentrations did not affect the coimmunoprecipita-
tion pattern of DLK-1L and DLK-1S (Figure S5B). Incubation with
BAPTA-AM blocked the effect of ionomycin treatment (Figures
8A and 8B), indicating that the change in association between
DLK-1Lwith DLK-1L or DLK-1S induced by ionomycin treatment
is likely due to the transient increase of intracellular Ca2+ levels.
Both the yeast two-hybrid protein interaction studies and
in vivo transgene expression have shown that the DLK-1L
C-terminal aa 856–881 region regulates the interactions between
DLK-1 isoforms (Figures 2 and 3C). We wondered whether this
region could be involved in Ca2+-dependent modulation of
DLK-1 isoform-specific interactions. We found that DLK-1L
and the mutants DLK-1L(D856–881), DLK-1L(D874–879), and
DLK-1L(S874A, S878A) bound to DLK-1S to a similar degree
under normal culture condition (Figures 8C, 8D, and S5A), con-
sistent with the yeast two-hybrid interactions. However, ionomy-
cin treatment did not cause detectable binding partner changes
of the mutants DLK-1L(D856–881), DLK-1L(D874–879), and
DLK-1L(S874A, S878A). We also found that DLK-1L(S874E,
S878E) showed strong binding to itself even without ionomycin
treatment (Figure S5A). These results support the idea that C
terminus of DLK-1L is required for the dissociation of DLK-1L/
S heteromeric complexes caused by increasing Ca2+ levels.
To test whether Ca2+ played a regulatory role in vivo, we next
analyzed GFP-DLK-1L dynamics in egl-19(ad695 gf) animals,
which is a gain-of-function mutation in the Ca2+ channel (Kerr
et al., 2000; Lee et al., 1997). Previous studies have shown that
Neuron
DLK-1 Activation by Isoform-Specific Interactionsegl-19(gf) enhances Ca2+ influx in PLM neurons after axotomy
(Ghosh-Roy et al., 2010). We found that egl-19(gf) mutants also
displayed significantly increased accumulation of GFP-DLK-1L
at cut sites, compared to wild-type (Figure 8E, juEx2529). In
contrast, neither DLK-1S nor DLK-1L(D856–881) showed local
changes upon immediate axonal injury in egl-19(gf) or wild-
type (Figure 8E, juEx2531, juEx4932). These data suggest that
a transient increase in Ca2+ levels, as caused by axonal injury
or synaptic activity, can trigger the release of DLK-1L from inhi-
bition by DLK-1S and that this dissociation may be influenced by
the phosphorylation state of the C-terminal hexapeptide.
DISCUSSION
The DLK kinases play key roles in synapse and axon develop-
ment and axon regeneration (Chen et al., 2011; Collins et al.,
2006; Hammarlund et al., 2009; Itoh et al., 2009; Lewcock
et al., 2007; Nakata et al., 2005; Xiong et al., 2010; Yan et al.,
2009; Shin et al., 2012). In particular, timely activation of DLK
kinases is critical for early responses to axonal injury (Chen
et al., 2011; Hammarlund et al., 2009). In this study, we have
uncovered a regulatory mechanism that endows C. elegans
DLK-1 kinase with the ability to be rapidly activated by axon
injury. We find that the short isoform, DLK-1S, acts as an endog-
enous inhibitor of the active long isoform DLK-1L. Our data
support a model in which the balance between the active DLK-
1L homomeric complexes and inactive DLK-1L/S heteromeric
complexes can be spatially and temporally regulated by the
conserved hexapeptide in a stimulus- or Ca2+-dependent
manner (Figure S6). This regulation is mediated via a C-terminal
hexapeptide that is highly conserved in the DLK-1 andMAP3K13
family. Our observation that human MAP3K13 can functionally
complement C. elegans DLK-1 suggests unexplored roles of
MAP3K13 in axon injury and hints at the possibility that similar
kinase activation mechanisms may apply to vertebrate neurons.
DLK-1 Activity and Spatial Control of Signal
Transduction in Neurons
Our observation that the inhibitory DLK-1S colocalizes with DLK-
1L in axons and synapses in a manner dependent on its binding
to DLK-1L supports a conclusion that most DLK-1 proteins are
maintained in an inactive state in uninjured axons (Figure S6A).
We also find that axotomy promotes accumulation of DLK-1L,
but not of DLK-1S, at the tips of severed axons and that
increasing intracellular Ca2+ can abrogate DLK-1L/DLK-1S het-
eromeric interaction. Injury triggers rapid Ca2+ transients, which
can promote an axon regenerative response (Ghosh-Roy et al.,
2010). We find that egl-19(gf) further enhances DLK-1L accumu-
lation at the cut site. Thus, we speculate that such Ca2+ tran-
sients may contribute to the dissociation of DLK-1L from
DLK-1Sat the injury site. In developing neurons, DLKproteins are
enriched at synaptic terminals. Overactivation of DLK kinases
disrupts synapses and axon growth and termination (Nakata
et al., 2005; Yan et al., 2009). The PHR E3 ligases, which are
localized adjacent to DLKs at synapses, provide one level of
control of signal transduction through ubiquitin-mediated protein
degradation of the activated kinases (Abrams et al., 2008; Na-
kata et al., 2005). Synaptic activity triggers Ca2+ transients,and therefore could also locally activate DLK kinases, in a similar
manner to axon injury. Indeed, it was reported that depolariza-
tion, which is coupled with changes in Ca2+ levels, can activate
mouse DLK in cell lines (Mata et al., 1996). The isoform-specific
regulation of DLK-1 activity by Ca2+ reported here has further
advanced our understanding of how developing synapses can
be regulated in an activity-dependent manner. Together, our
data have revealed an unexpected mode of MAP kinase activa-
tion that is ideally suited for spatial and temporal control of DLK
signal transduction in neurons.
Activation Mechanism of DLK-1 as MAPKKKs
A striking observation in our study is that the inhibitory effect of
DLK-1S does not depend on its kinase activity. This implies
that DLK-1S binding sterically hinders DLK-1L activity. We find
that the C terminus of DLK-1L is necessary for its activity and
for its localization. Within the C terminus, we have identified
a domain that can bind the kinase domain and influence DLK-
1L and DLK-1S heteromeric interactions. Remarkably, the con-
served core of this domain, the SDGLSD hexapeptide, is com-
pletely conserved from C. elegans DLK-1 to human MAP3K13.
This hexapeptide does not match known Ca2+ binding sites
or known phosphorylation consensus sites. However, both the
hexapeptide and neighboring sequences are rich in charged
amino acid residues, suggesting a possible role in sensing ionic
changes. Our phosphomimetic manipulations suggest that the
charge state of this hexapeptide can tip the balance of DLK-1
homo- and heteromeric interactions. These observations imply
involvement of Ca2+- or injury-triggered kinases, the identity of
which remains to be addressed in the future.
MAPKKKs provide stimulus specificity in signal transduction
cascades and must be maintained in inactive states under basal
conditions (Craig et al., 2008; L’Allemain, 1994). Most MAPKKKs
contain regulatory domains in addition to the kinase domain. A
well-known example is Raf MAPKKK (Chong et al., 2003), which
is maintained in an inactive state by binding of an N-terminal
regulatory region to its kinase domain (Pumiglia et al., 1995).
Release of this autoinhibition involves several proteins that
bind to various regions of Raf, culminating with kinase activation
by homo- or heterodimerization with its activation partner KSR
(Fantl et al., 1994; Freed et al., 1994; Xing et al., 1997). Similarly,
the N terminus of MTK1/MEKK4 MAPKKK binds to and inhibits
its kinase domain, and stress signals activate GADD45 proteins
that bind to the N terminus, causing dissociation of the kinase
domain and activation of MTK1 through protein dimerization
(Mita et al., 2002; Miyake et al., 2007; Takekawa and Saito,
1998).
To our knowledge, there is no exact precedent among
MAPKKKs for the mechanism of DLK-1 activation. Although
many MAP kinases are known to self-activate through kinase
dimerization (Mita et al., 2002; Miyake et al., 2007; Takekawa
andSaito, 1998),DLK-1L/Sheteromericbindingdoesnotactivate
DLK-1L. Notably, presence of the C-terminal domain in the DLK-
1L/S heteromeric state is not sufficient to trigger DLK-1L activa-
tion. We envision one possible activation mode that may involve
conformational changes of the homomeric kinase domain medi-
ated by an intermolecular interaction between the kinase domain
and the C-terminal activation domain (Figure S6B). In neurons,Neuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc. 543
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DLK-1 Activation by Isoform-Specific Interactionsregulation of kinase activity byCa2+ iswell known.However,most
Ca2+-dependent kinases either bindCa2+directly or are regulated
by Ca2+-binding proteins, as in the case of CamKII (Meador et al.,
1993). Ca2+/calmodulin binding causes phosphorylation of the
internal CamKII peptide and changes the holoenzyme conforma-
tion, leading to kinase activation (Yang and Schulman, 1999;
Chao et al., 2011). Although several DLK kinase-binding proteins
have been reported (Fukuyama et al., 2000; Horiuchi et al., 2007;
Ghosh et al., 2011;Whitmarsh et al., 1998), none have been asso-
ciated with Ca2+. Our studies therefore provide new insights for
a structural understanding of DLK kinases.Implications for Function Conservation of the DLK
Family of Proteins
The C. elegans and Drosophila DLK kinases are orthologous
to two closely related vertebrate MAPKKKs, DLK/MUK/ZPK/
MAP3K12 and LZK/MAP3K13 (Holzman et al., 1994; Sakuma
et al., 1997). MAP3K12 and MAP3K13 display >95% sequence
identity in their kinase domain, but their C termini diverge signif-
icantly. It has been shown that the LZ domain of MAP3K13 can
mediate dimerization but is not sufficient to activate MAP3K13
(Ikeda et al., 2001). MAP3K12 and MAP3K13 are known to acti-
vate different downstream kinases in cultured cells (Ikeda et al.,
2001; Nihalani et al., 2000) and may have opposite roles in regu-
lating neurite outgrowth (Dickson et al., 2010; Eto et al., 2010).
Wehaveshown that theC-terminal aa856–881domainofDLK-
1L can bind to the kinase domain of both human MAP3K13 and
C. elegans DLK-1. Expression of human MAP3K13 in C. elegans
neurons can functionally complement dlk-1. The DLK-1L hexa-
peptide is completely conserved in MAP3K13 but not in
MAP3K12. Short isoforms for MAP3K12 are detected as ESTs;
MAP3K12 and MAP3K13 can form homomers or heteromers
(Ikeda et al., 2001; Nihalani et al., 2000). Thus far, most reported
studies have focused on the MAP3K12/DLK, and different types
of neurons lacking DLK show a range of phenotypes from neurite
regeneration to axon degeneration and to neuronal death (Ghosh
et al., 2011; Itoh et al., 2009, 2011; Miller et al., 2009). At present,
much less is known about MAP3K13/LZK, although it has been
implicated in neurite outgrowth and may interact with the re-
growth inhibitor Nogo (Dickson et al., 2010).Figure 8. High Concentrations of Intracellular Ca2+ Can Trigger Dissoc
(A and B) Increasing intracellular Ca2+ concentration alters binding interactions be
coexpressed in HEK293 cells at ratio of 1:1:2. Cells were treated with 3 mM ionomy
were used for immunoprecipitation of DLK-1L, and 7%SDS-PAGE gels were used
were used for western blot to detect coimmunoprecipitated HA-DLK-1L or HA-D
FLAG-DLK-1L. Five percent protein lysis before IP was shown as input.
(A) Images of western blots.
(B) Quantification of immunoprecipitated HA-DLK-1L and HA-DLK-1S under diffe
then normalized by coimmunoprecipitated DLK-1L or DLK-1S in untreated gro
different treatments is shown as mean ± SEM. Top, DLK-1L; bottom, DLK-1S. S
(C and D) DLK-1L C-terminal conserved domain is important for Ca2+ regulation
HEK293 cells in the same ratio as in (A) and (B). Cells were treatedwith ionomycin.
1L abolishes the effect of ionomycin.
(C) Images of western blots.
(D) Quantification data. n = 4. Data are shown as mean ± SEM; statistics, Studen
(E) Increase of Ca2+ influx by an egl-19(gf) mutation further enhances accumu
881)(juEx4932) at cut sites after axotomy. Experimental conditions and data ana
Student’s t test: **p < 0.01, *p < 0.05, ns, not significant; nR 10 from two indepOur discovery of antagonistic C. elegans DLK-1 isoforms,
together with our demonstration of functional conservation of
DLK-1L and MAP3K13/LZK, suggest that the activation mecha-
nisms of DLK family MAPKKKs in neurons may be conserved.
Specifically, we speculate that MAP3K13 could also be kept
in an inhibited state by an endogenous inhibitory isoform. As
MAP3K12 and MAP3K13 are almost identical in their kinase
and LZ domains, MAP3K12 isoforms could provide this inhibi-
tory function. Clearly, it will be informative to assess the role of
MAP3K13 in synaptic development and axon regrowth and its
possible crosstalk with MAP3K12.
EXPERIMENTAL PROCEDURES
C. elegans Genetics
WemaintainedC. elegans strains on NGMplates at 20C–22.5C as described
by Brenner (1974). The dlk-1 mutations are listed in Table S1; mutations
affecting the kinase domain are shown in Figure S1B. We used juIs1[Punc-
25-SNB-1::GFP] for viewing GABA motor neuron synapses (Hallam and Jin,
1998), andmuIs32[Pmec-7-GFP] (Ch’ng et al., 2003) for viewing touch neuron
morphology and axon regeneration studies. Other transgenes and strains are
described in Table S2.
Fluorescence Microscopy
We scored fluorescent reporters in live animals using a Zeiss Axioplan 2micro-
scope equipped with Chroma HQ filters. For quantification of touch neuron
morphology using muIs32, 100–150 1-day-old adults were analyzed. For
quantification of GABAergic motor neuron synapse morphology using juIs1,
confocal images of dorsal cords in the midbody were collected on 1-day-old
adults immobilized in 1% 1-phenoxy-2-propanol (TCI America) in M9 buffer.
For GFP-DLK-1L, GFP-DLK-1S, and CFP-DLK-1L/YFP-DLK-1S, images
were collected from 1-day-old adults using a Zeiss LSM510 confocal micro-
scope. For synapse morphology and DLK-1L/S localization, z stack images
(1 mm/section) were shown in the figures.
Laser Axotomy
We cut PLM axons in anesthetized L4 larvae using a near-infrared Ti-Sapphire
laser (KMLabs) as described (Wu et al., 2007). To image the dynamics of GFP-
DLK-1L/S in Figure 7, we immobilized animals using 6 mM levamisole (Sigma)
in M9 buffer as described (Ou et al., 2010) and took pictures using a Yokogawa
CSU-XA1 spinning-disc confocal microscope with a Photometrics Cascade
II EMCCD camera (1024 3 1024), controlled by mManager (http://www.
micro-manager.org). One image was taken right before axotomy, and images
were collected every 9 s for 7min postaxotomy. To visualize the axons for laseriation of DLK-1L/DLK-1S and Promote Binding between DLK-1L
tween DLK-1L and DLK-1S. FLAG-DLK-1L, HA-DLK-1L, and HA-DLK-1S were
cin, with or without 10 mMBAPTA-AM, for 15min. Rabbit anti-FLAG antibodies
to separate proteins of different molecular weights. Mouse anti-HA antibodies
LK-1S. Rabbit anti-FLAG antibodies were used to show immunoprecipitated
rent treatments. The intensities of bands were first normalized to the input and
ups. The amount of coimmunoprecipitated proteins bound to DLK-1L under
tatistics, Student’s t test: **p < 0.01, ns, not significant; n = 5.
. Full-length DLK-1L or DLK-1L(D856–881) was coexpressed with DLK-1S in
IP experiments were performed as in (A) and (B). Deletion of aa 856–881 in DLK-
t’s t t test: **p < 0.01, ns, not significant; n = 5.
lation of GFP-DLK-1L(juEx2529) but not DLK-1S(juEx2531) or DLK-1L(D856-
lysis are the same as in Figure 7. Data are shown as mean ± SEM; statistics,
endent recordings.
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DLK-1 Activation by Isoform-Specific Interactionsaxotomy in GFP-DLK-1L/S dynamic experiments, we used 0.5 s exposure
time, which was much longer than in the localization analysis in Figure 5.
The fluorescence intensity of the first 3 mm axon fragments near cut sites
was measured using MetaMorph (Molecular Devices). A comparable nonaxo-
nal region of interest was also measured as background. For the quantification
of GFP-DLK-1L/S protein level after axotomy, the intensity of each time point
(Ft = Fi Fb; Ft, fluorescence intensity at time point t; Fi, fluorescence intensity
of the region of interest; Fb, intensity of the background) was normalized by the
intensity at axotomy (F0).
Statistical Analysis
In comparisons of measurement of axonal regrowth in Figure 6, we used one-
tailed Student’s t test. Comparisons involving multiple groups used one-way
ANOVA and Bonferroni posttests in Graphpad Prism (GraphPad Software).
To compare variables such as axon termination proportions in Figure 1, 2,
and 4, we used Fisher’s exact test.
Protein Analysis and Yeast Two-Hybrid Assays
For expression studies in 293 T cells, full-length dlk-1L and dlk-1S cDNAs were
cloned into pcDNA3-HA or pcDNA-FLAG to generate pCZGY1711(FLAG-
DLK-1 L), pCZGY1710(HA-DLK1L), pCZGY1709(HA-DLK-1S), pCZGY1708
(FLAG-DLK-1L(D856–881)), and pCZGY1707(HA-DLK-1L(D856–881)). Cells
were cultured using standard procedures in Dulbecco’s modified Eagle’s
medium (Nakata et al., 2005). Lipofectamine 2000 (Invitrogen) was used in
cell transfection. One day after transfection, cells were treated with 3 mM Ion-
omycin (Cell Signaling Technology, 9995) with or without BAPTA-AM (10 mM)
(Sigma, 126150-97-8) for 15 min and lysed using radioimmunoprecipitation
buffer (25 mM Tris-HCl [pH 7.4], 150 mM KCl, 5 mM EDTA, 1% NP-40, 0.5%
sodium deoxycholate, and 0.1% SDS, and protease inhibitor cocktail; Roche
Applied Science). Equivalent amounts of lysates were incubated with rabbit
anti-FLAG (Sigma, F7425) for 6–8 hr at 4C. Immune complexes were precip-
itatedwith protein A agarose (GEHealthcare) for 1 hr at 4C,washed four times
with lysis buffer, and eluted by heating to 95C for 5 min in SDS sample buffer
containing 1 mM DTT. Blots were probed with rabbit anti-FLAG antibodies
(Sigma, F7425) or a mouse anti-HA monoclonal antibody (Cell Signaling,
2367). The blot was visualized with Amersham HRP-conjugated anti-rabbit
or anti-mouse secondary antibodies at 1:5,000 (Amersham) using the Super-
Signal West Femto kit (Pierce).
Yeast two-hybrid assays were performed using pACT2 and pBTM166
vectors (Clontech). DLK-1 cDNAs encoding full-length or fragment of the
protein were fused to the GAL4 DNA binding domain in pACT2 or the GAL4
activation domain in pBTM166. Pairs of plasmids were cotransformed into
yeast strain L40 and selected on Trp– Leu– plates to obtain double transform-
ants. Single clone was picked from each transformation and cultured until
OD600 = 1. Pellets of yeast cells were collected by centrifugation, washed three
times and resuspended in water, and plated in a dilution series of 10 to 1,000
times by pipeting 5 ml per spot onto Histidine selection plates containing
10 mM 3-AT.
mRNA Analysis
Total RNA was isolated using TRIzol (Invitrogen) from mixed stage worms
cultured under identical conditions. We reverse transcribed 5 mg of total
RNA into cDNA using an oligo dT primer (Invitrogen). Primers (F(YJ8377):
50AATACAGAGGAAGCGGCATGAG; R(YJ8378): 50CGGAAATCCCGTGGATA
ATG) were used to specifically detect DLK-1S transcript; ama-1 was used
as internal control. To determine the 30 ends of DLK-1L and DLK-1S, we
used the 30RACE kit (Invitrogen) and nestED PCR with the following
primers: for DLK-1L, F1(YJ8379): 50CAGAGGAAGCGGCATGAG; for DLK-
1S, F2(YJ8380): 50GAGCAGTGGCACAATCAGAAC. We obtained two DNA
fragments and confirmed that their sequences corresponded to the two
isoforms of DLK-1. We also analyzed two cDNA clones provided by Yuji
Kohara (National Institute of Genetics, Mishima, Japan); yk826d12 contained
30 sequences and UTR matching DLK-1S, and yk674b2 contained 30
sequences and UTR matching DLK-1L. Northern blotting was done following
the protocol as described (Bagga et al., 2005). We ran 60 mg total RNA
from mixed stage N2 for northern blot. Probes were made using the Prime-It
II Random Primer Labeling Kit (Stratagene, 300385) with a template containing546 Neuron 76, 534–548, November 8, 2012 ª2012 Elsevier Inc.1.65 kb cDNA fragment that covered the entire common region for DLK-1L and
DLK-1S.
DNA Constructs and Generation of Transgenes
All DNA expression constructs were made using Gateway cloning technology
(Invitrogen). Sequences of the final clones were confirmed. The information for
each construct is in Table S2. The primer sequences are included in the
Supplemental Information or are available upon request.
Transgenic animals were generated following standard procedures (Mello
et al., 1991). In general, plasmid DNAs of interest were used at 1–50 ng/ml
with the coinjection marker Pttx-3-RFP at 50 ng/ml. For each construct, three
to ten independent transgenic lines were analyzed. Table S2 lists the geno-
types and DNA constructs for the transgenes. Mos-SCI transgenic worms
were generated at the Ch II ttTi5606 site as described (Frøkjaer-Jensen
et al., 2008). The rgef-1 promoter, dlk-1L/S cDNA, and unc-54 30UTR were re-
combined into pCFJ150 by three-way LR reactions to generate Prgef-1-DLK-
1L(pCZGY1705) and Prgef-1-DLK-1S(pCZGY1704) Mos-SCI plasmids. These
plasmids were injected into EG4322 (ttTi5605 II; unc-119(ed3) III; oxEx1578) to
generate single-copy insertion. Primers (F (YJ8987): 50GGAGTTCGGACA
GAAAGAAG30 and R (YJ8988): 50AGCCATTCAAGTTCGGAGATAG30) were
used to distinguish Mos-SCI dlk-1 cDNA from genomic dlk-1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
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